Stratec SE (FRA:SBS)
26.75
-1.05 (-3.78%)
Last updated: Aug 1, 2025
Stratec SE Company Description
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally.
The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers.
It also provides consumables for diagnostics and medical applications; and integrating instrumentation and software.
The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.
Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Stratec SE
Country | Germany |
Founded | 1979 |
Industry | Laboratory Analytical Instruments |
Employees | 1,387 |
CEO | Marcus Wolfinger |
Contact Details
Address: Gewerbestrasse 37 Birkenfeld, 75217 Germany | |
Phone | 49 7082 7916 0 |
Website | stratec.com |
Stock Details
Ticker Symbol | SBS |
Exchange | Frankfurt Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | EUR |
SIC Code | 3826 |
Key Executives
Name | Position |
---|---|
Marcus Wolfinger | Chief Executive Officer |
Oliver Albrecht | Chief Financial Officer |
Jan Keppeler | Head of Investor Relations |